Innovative Visualization SentiAR’s pioneering use of real-time 3D holography and augmented reality technology in interventional procedures positions it as a leader in medical visualization solutions, offering potential for sales expansion into hospitals seeking cutting-edge surgical support systems.
Strong Funding Momentum With recent Series A and Series B funding totaling $17 million, SentiAR demonstrates robust investor confidence and financial stability, enabling further product development and broader market outreach to healthcare providers.
Recognition & Awards The company’s multiple industry awards highlight its innovative design and user interaction excellence, providing a compelling value proposition to medical institutions prioritizing advanced, award-winning technology solutions.
Strategic Partnerships Spun out of Washington University and licensed from the Silva lab, SentiAR’s collaboration with academic and research institutions offers opportunities to build strategic alliances for clinical trials, joint research, and early adoption advocacy.
Emerging Market Focus Targeting the growing field of AR-assisted surgical procedures, SentiAR can deepen engagement with cardiac and interventional cardiology centers looking to enhance procedural safety and precision with innovative visualization tools.